BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 6313814)

  • 1. Common expression of varicella-zoster viral glycoprotein antigens in vitro and in chickenpox and zoster vesicles.
    Weigle KA; Grose C
    J Infect Dis; 1983 Oct; 148(4):630-8. PubMed ID: 6313814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies against three major glycoproteins of varicella-zoster virus.
    Grose C; Edwards DP; Friedrichs WE; Weigle KA; McGuire WL
    Infect Immun; 1983 Apr; 40(1):381-8. PubMed ID: 6299963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization epitope of varicella zoster virus on native viral glycoprotein gp118 (VZV glycoprotein gpIII).
    Montalvo EA; Grose C
    Virology; 1986 Mar; 149(2):230-41. PubMed ID: 2418586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response.
    Brunell PA; Novelli VM; Keller PM; Ellis RW
    J Infect Dis; 1987 Sep; 156(3):430-5. PubMed ID: 3039010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dissection of the humoral immune response to individual varicella-zoster viral proteins during chickenpox, quiescence, reinfection, and reactivation.
    Weigle KA; Grose C
    J Infect Dis; 1984 May; 149(5):741-9. PubMed ID: 6327848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody to early antigens of varicella-zoster virus during varicella and zoster.
    Gerna G; Cereda PM; Cattaneo E; Achilli G; Gerna MT
    J Infect Dis; 1979 Jul; 140(1):33-41. PubMed ID: 88490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response after exposure to varicella zoster virus: characterization of virus-specific antibodies and their corresponding antigens.
    Zweerink HJ; Neff BJ
    Infect Immun; 1981 Jan; 31(1):436-44. PubMed ID: 6260665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of a varicella-zoster virus glycoprotein E epitope.
    Vafai A; Forghani B; Kilpatrick D; Ling J; Shankar V
    Arch Virol; 2000; 145(1):85-97. PubMed ID: 10664408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
    Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
    Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection and persistence of varicella-zoster virus in lymphoblastoid Raji cell line.
    Leventon-Kriss S; Gotlieb-Stematsky T; Vonsover A; Smetana Z
    Med Microbiol Immunol; 1979; 167(4):275-83. PubMed ID: 232537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of varicella-zoster virus (VZV) fluorescent-antibody-to-membrane-antigen (FAMA) testing on sensitivity of determining VZV immunity in healthcare workers and on furlough days.
    Rolando L; Schneider WJ; Steinberg S; Low S; Stiles J; Gomez L; Gershon AA; Brown AE
    Infect Control Hosp Epidemiol; 2010 Sep; 31(9):972-4. PubMed ID: 20666603
    [No Abstract]   [Full Text] [Related]  

  • 12. Human leukocytes kill varicella-zoster virus-infected fibroblasts in the presence of murine monoclonal antibodies to virus-specific glycoproteins.
    Ito M; Ihara T; Grose C; Starr S
    J Virol; 1985 Apr; 54(1):98-103. PubMed ID: 2983124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties.
    Montalvo EA; Parmley RT; Grose C
    J Virol; 1985 Mar; 53(3):761-70. PubMed ID: 2983087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenic glycoproteins of laboratory and vaccine strains of Varicella-Zoster virus.
    Grose C; Edmond BJ; Friedrichs WE
    Infect Immun; 1981 Mar; 31(3):1044-53. PubMed ID: 6262245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme-linked immunosorbent assay for detection of virus-specific IgM antibodies to varicella-zoster virus.
    Hacham M; Leventon-Kriss S; Sarov I
    Intervirology; 1980; 13(4):214-22. PubMed ID: 6248482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of varicella-zoster virus-infected cell proteins that elicit antibody production during primary varicella using the immune transfer method.
    Palumbo PE; Arvin AM; Koropchak CM; Wittek AE
    J Gen Virol; 1984 Dec; 65 ( Pt 12)():2141-7. PubMed ID: 6096492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varicella-zoster virus-specific gp140: a highly immunogenic and disulfide-linked structural glycoprotein.
    Grose C; Edwards DP; Weigle KA; Friedrichs WE; McGuire WL
    Virology; 1984 Jan; 132(1):138-46. PubMed ID: 6320530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM and IgG responses to varicella-zoster virus p32/p36 complex after chickenpox and zoster, congenital and subclinical infections, and vaccination.
    Harper DR; Grose C
    J Infect Dis; 1989 Mar; 159(3):444-51. PubMed ID: 2536788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen.
    Sauerbrei A; Wutzler P
    J Clin Microbiol; 2006 Sep; 44(9):3094-7. PubMed ID: 16954232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of varicella-zoster viral antigens in clinical specimens by solid-phase enzyme immunoassay.
    Ziegler T
    J Infect Dis; 1984 Jul; 150(1):149-54. PubMed ID: 6086769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.